Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer
The findings support evaluating targeting kinase enzymes in a clinical trial to treat this type of breast cancer.
Read More
ER+ breast cancer
Immune checkpoint therapy for ER+ breast cancers, a missed opportunity?
In the United States, apart from some forms of skin cancer, breast cancer is the most common cancer in women. It is also the most
Read More